HIV Cure Research Information Sheet
Research into curing HIV infection is ever-changing as new discoveries are made and scientists report additional rare — but informative — cases of individuals likely cured of HIV.
ANEA and TAG Stand in Solidarity with Demonstrators Fighting to Save PEPFAR
The ACT NOW: END AIDS Coalition (ANEA) and Treatment Action Group (TAG) are proud to stand in solidarity with activists demonstrating today at the U.S. Capitol demanding that the U.S. government restore full funding to the President’s Emergency Plan for AIDS Relief (PEPFAR)
TAG Fiercely Condemns the New Administration’s War on Science
Treatment Action Group (TAG) is disgusted and appalled by the new presidential administration’s flagrant attack on science.
2025 Pre-CROI Community HIV Cure Research Workshop
The 2025 Pre-CROI Community HIV Cure Research Workshop will take place on Saturday, March 8 in San Francisco.
TAG Joins Allies at State Department to Demand Full Restoration of US Support for Global AIDS Programs
Treatment Action Group (TAG) fiercely condemns the new presidential administration’s deadly and hateful attack on people living with HIV and their communities at home and around the world.
Community Surveys Show Enthusiasm for Long-Acting HCV Cure Research
People living with or at risk of hepatitis C Virus (HCV), health care providers, and policymakers in low- and middle-income countries (LMICs) showed significant interest in a potential long-acting HCV cure, recent surveys have found.
TAG Condemns Planned U.S. Withdrawal from WHO
Treatment Action Group (TAG) is appalled by President Donald Trump’s executive order Monday signaling the United States will be withdrawing from the World Health Organization (WHO).
TAG’s Submission to the Office of the High Commissioner for Human Rights (OHCHR)
TAG submitted this this input for the Office of the High Commissioner on Human Rights (OHCHR), in response to its request for "Inputs for the comprehensive report, incl. new developments, in ensuring access to medicines, vaccines and other health products."
2024 Report on TB Research Funding Trends
A new report released today by Treatment Action Group (TAG) and Stop TB Partnership found that cumulative funding for tuberculosis (TB) research and development (R&D) in 2023 reached only 24% of the annual $5 billion funding target agreed by countries at the United Nations High-Level Meeting (HLM) on TB in September 2023.
TB R&D Funding: Billions Short and Reliant on a Few Major Donors, New Report Finds
A new report released today by Treatment Action Group (TAG) and Stop TB Partnership found that cumulative funding for tuberculosis (TB) research and development (R&D) in 2023 reached only 24% of the annual $5 billion funding target agreed by countries at the United Nations High-Level Meeting (HLM) on TB in September 2023.